Suppr超能文献

饮食对艰难梭菌感染的影响:综述

The Impact of Diet on Clostridioides difficile Infection: A Review.

作者信息

Castro Melissa, Silver Heidi J, Hazleton Keith, Lozupone Catherine, Nicholson Maribeth R

机构信息

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

出版信息

J Infect Dis. 2025 Jul 11;231(6):e1010-e1018. doi: 10.1093/infdis/jiaf233.

Abstract

Clostridioides difficile poses a significant public health challenge as it is the leading cause of antibiotic-associated diarrhea and is associated with significant morbidity and mortality. Clostridioides difficile's metabolism and pathogenesis are strongly influenced by nutrient availability from the host and gut commensals. This has caused increasing interest in dietary intake and diet-derived metabolites' role in C difficile infection (CDI). Although much of the data currently originates from animal models, there is growing evidence of the ability of diet to impact CDI-related outcomes. This review aims to enrich the understanding of dietary components that impact C difficile metabolism and pathogenesis, as well as provide limitations in the current science to support future inquiry. Without a better understanding of the influence of diet on CDI in the human host, we lack a nonpharmacologic approach to prevent and treat this important condition.

摘要

艰难梭菌对公共卫生构成了重大挑战,因为它是抗生素相关性腹泻的主要病因,且与显著的发病率和死亡率相关。艰难梭菌的代谢和发病机制受到来自宿主和肠道共生菌的营养物质可用性的强烈影响。这使得人们越来越关注饮食摄入以及饮食衍生代谢产物在艰难梭菌感染(CDI)中的作用。尽管目前的许多数据来自动物模型,但越来越多的证据表明饮食有能力影响与CDI相关的结果。本综述旨在加深对影响艰难梭菌代谢和发病机制的饮食成分的理解,并指出当前科学研究中的局限性,以支持未来的探究。如果不能更好地理解饮食对人类宿主中CDI的影响,我们就缺乏预防和治疗这种重要疾病的非药物方法。

相似文献

1
The Impact of Diet on Clostridioides difficile Infection: A Review.
J Infect Dis. 2025 Jul 11;231(6):e1010-e1018. doi: 10.1093/infdis/jiaf233.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
4
Host origin of microbiota drives functional recovery and clearance in mice.
mBio. 2025 Jun 2:e0110825. doi: 10.1128/mbio.01108-25.
5
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
6
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Cochrane Database Syst Rev. 2013 May 31(5):CD006095. doi: 10.1002/14651858.CD006095.pub3.
7
Roles of Gut Microbiota and Associated Metabolites in Infection.
Pol J Microbiol. 2025 Jun 18;74(2):206-217. doi: 10.33073/pjm-2025-017. eCollection 2025 Jun 1.
8
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Cochrane Database Syst Rev. 2007 Jul 18(3):CD004610. doi: 10.1002/14651858.CD004610.pub3.
9
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004610. doi: 10.1002/14651858.CD004610.pub2.
10
The evolving landscape of live biotherapeutics in the treatment of Clostridioides difficile infection.
Indian J Gastroenterol. 2025 Apr;44(2):129-141. doi: 10.1007/s12664-024-01717-9. Epub 2025 Jan 16.

本文引用的文献

1
Fiber- and acetate-mediated modulation of MHC-II expression on intestinal epithelium protects from Clostridioides difficile infection.
Cell Host Microbe. 2025 Feb 12;33(2):235-251.e7. doi: 10.1016/j.chom.2024.12.017. Epub 2025 Jan 17.
2
The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization.
Am J Gastroenterol. 2025 Jan 1;120(1):98-105. doi: 10.14309/ajg.0000000000003085. Epub 2024 Sep 19.
3
and Gut Microbiota: From Colonization to Infection and Treatment.
Pathogens. 2024 Jul 31;13(8):646. doi: 10.3390/pathogens13080646.
5
Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in .
mBio. 2024 Mar 13;15(3):e0253523. doi: 10.1128/mbio.02535-23. Epub 2024 Jan 30.
6
Gut Microbiota-Gut Metabolites and Infection: Approaching Sustainable Solutions for Therapy.
Metabolites. 2024 Jan 22;14(1):74. doi: 10.3390/metabo14010074.
7
Clostridioides difficile infections; new treatments and future perspectives.
Curr Opin Gastroenterol. 2024 Jan 1;40(1):7-13. doi: 10.1097/MOG.0000000000000989. Epub 2023 Nov 9.
8
Butyrate enhances sporulation .
J Bacteriol. 2023 Sep 26;205(9):e0013823. doi: 10.1128/jb.00138-23. Epub 2023 Sep 1.
9
Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism.
Microbiol Spectr. 2023 Aug 17;11(4):e0447922. doi: 10.1128/spectrum.04479-22. Epub 2023 Jun 23.
10
Characterization of the gut microbiome of patients with infection, patients with non- diarrhea, and -colonized patients.
Front Cell Infect Microbiol. 2023 Apr 12;13:1130701. doi: 10.3389/fcimb.2023.1130701. eCollection 2023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验